Close

Bausch Health Companies (BHC) PT Raised to $30 at Deutsche Bank

Go back to Bausch Health Companies (BHC) PT Raised to $30 at Deutsche Bank

Bausch Health Companies (BHC) PT Raised to $26 at RBC Capital

August 8, 2018 8:12 AM EDT

RBC Capital raised its price target on Bausch Health Companies (NYSE: BHC) to $26.00 (from $25.00) while maintaining a Sector Perform rating.

... More

Bausch Health Companies (BHC) Reports Q2 Revenues of $2.125B; Boosts FY18 Adj. EBITDA Guidance, Offers FY18 Revenue Outlook

August 7, 2018 7:23 AM EDT

Bausch Health Companies (NYSE: BHC) reported Q2 revenue for the quarter came in at $2.13 billion.

Revenues of $2.128 BillionGAAP Net Loss of $873 MillionGAAP Cash Flow from Operations of $222 MillionAdjusted EBITDA (non-GAAP)1 of $868 MillionDelivered Second Consecutive Quarter of Overall Organic Revenue Growth2, Driven by the Salix... More